{"id":"W4283798787","doi":"10.1053/j.gastro.2022.06.068","title":"CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease","year":2022,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; University of Toronto; Mount Sinai Hospital; St. Paul's Hospital; University of Calgary; McGill University; University of British Columbia; University of Manitoba","funders":"Canadian Institutes of Health Research; Takeda Canada; Pfizer Canada; Shire; Genentech; Prometheus Biosciences; Bristol-Myers Squibb Canada; Protagonist Therapeutics; Janssen Pharmaceuticals; Gilead Sciences; AbbVie Canada; Seres Therapeutics; Janssen Canada; Amgen Canada; Sanofi; Roche; GlaxoSmithKline; Pfizer","keywords":"Medicine; Calprotectin; Randomized controlled trial; Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; Clinical trial; Internal medicine; Clinical endpoint; Multidisciplinary approach; Delphi method; Outcomes research; Patient-reported outcome; Disease; Physical therapy; Quality of life (healthcare); Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005544738,0.0003554357,0.001584806,0.0003291814,0.0001616302,0.00002312508,0.0004377417,0.00009382796,0.0001358944],"category_scores_gemma":[0.01087533,0.0003246384,0.0006824126,0.00007691208,0.0001990669,0.000005384182,0.0006838531,0.0001976392,0.000009040739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001297365,"about_ca_system_score_gemma":0.0003811727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003821611,"about_ca_topic_score_gemma":0.00009300053,"domain_scores_codex":[0.9946536,0.002081084,0.001836139,0.0006236282,0.0002616159,0.0005439076],"domain_scores_gemma":[0.9975903,0.000719294,0.0007382754,0.0003541403,0.0003134101,0.0002845753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6804314,0.0001813859,0.3100105,0.00002957027,0.0006090894,0.0004183528,0.0003269702,0.002613324,0.002492786,0.0002197839,0.002648356,0.00001848654],"study_design_scores_gemma":[0.7392033,0.0008073552,0.2494413,0.00002982768,0.0004159473,0.00008133702,0.0009658585,0.00626404,0.00005471826,0.0008269846,0.001392964,0.000516346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891471,0.0000490452,0.001379166,0.001584678,0.001016569,0.005266772,0.00146147,0.00002719657,0.00006796594],"genre_scores_gemma":[0.9857129,0.000006812996,0.001255529,0.00293081,0.0002153676,0.008451838,0.001186906,0.00004495848,0.0001949098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06056918,"threshold_uncertainty_score":0.9999205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.063015279466745,"score_gpt":0.3478573483873491,"score_spread":0.284842068920604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}